Back
ESC Professional Premium Access

High levels of intermediate cd14++cd16+ monocytes predict incident atrial fibrillation in the general population

Session: The role of rate control and comorbidities in atrial fibrillation
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor K. Sveen (Oslo, NO)
Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Kari Anne Sveen

Oslo University Hospital Ulleval, Oslo (Norway)
0 follower

5 more presentations in this session

Interactions of circulating, digoxin-like, steroids with rate control therapy for atrial fibrillation in the RATE-AF randomised clinical trial

Speaker: Doctor I. Akoumianakis (Birmingham, GB)

Access
Abstract
Slides
Video
Thumbnail

Ranolazine is associated with a reduced incidence of atrial fibrillation in patients with chronic coronary syndrome: the results of a real-world analysis of an Italian population

Speaker: Associate Professor S. Fumagalli (Florence, IT)

Access
Abstract
Slides
Video
Thumbnail

The impact of sick sinus syndrome on flow velocity of the left atrial appendage in patients with atrial fibrillation

Speaker: Doctor S. Takahashi (Kobe, JP)

Access
Abstract
Slides
Video
Thumbnail

Clinical impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study

Speaker: Professor L. Fauchier (Tours, FR)

Access
Abstract
Slides
Video
Thumbnail

Is pre-diabetes a predictor of events in patients with atrial fibrillation?

Speaker: Doctor A. Ledo Pineiro (Vigo, ES)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

The role of rate control and comorbidities in atrial fibrillation

Speakers: Doctor K. Sveen, Doctor I. Akoumianakis, Associate Professor S. Fumagalli, Doctor S. Takahashi, Professor L. Fauchier...
Access
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb